Sky: Liberum upgrades to buy with a target price of 1,250p.
Speciality chemical company Croda International reported a record full-year profit on Tuesday as sales grew thanks to a strong performance across sectors and regions.
Speciality chemicals manufacturer Croda called off merger talks with US rival Ashland in January.
Berenberg upgraded speciality chemicals group Croda International to 'buy' from 'hold' and lifted the price target to 50p from 41.50p as it pointed to organic growth and the scope for cash returns.
Croda International plc: Berenberg upgrades to buy with a target price of 5,000p.
Speciality chemicals group Croda International has made two technology acquisitions for an undisclosed sum.
Mothercare: JP Morgan downgrades to underweight with a target price of 40p.
Shares in Croda International are also an "avoid" for Questor in the Sunday Telegraph. The company manufactures speciality and industrial chemicals used in many everyday items such as cosmetic creams, dietary supplements, foods, plastic bags and motor vehicles. It has progressed far since its days of refining grease from sheep's wool to make lanolin by employing clever people and rewarding them well, including with a final salary pension scheme, which is all part of management taking a long-term view and investing millions each year in research and development.
Speciality chemical company Croda International said on Tuesday that the improved sales trend seen in the first half of 2017 continued through the third quarter, with group constant currency sales up 4.4% in the quarter and 4.0% year-to-date.
Half year pre-tax profits at speciality chemical company Croda rose 15.8% to £168m boosted by currency tailwinds as sales increased 16.2% to £707.3m.
Schroders: RBC upgrades to Outperform with a target price of 3400p.
GlaxoSmithKline: Deutsche Bank reiterates Hold with a target price of 1700p.
High-performance ingredients and technology speciality chemicals company Croda International updated the market on its trading during the first quarter to 31 March on Wednesday, reporting that the improving sales trend seen in the fourth quarter of 2016 hax continued.
Analysts at Barclays expect the European chemicals sector to post one of its strongest first quarters in some time, thanks to pre-buying as prices for raw materials rise and after product spreads widened to "remarkable" levels over the first three months of 2017.
AstraZeneca: UBS downgrades to Neutral with a target price of 5150p.
Credit Suisse downgraded Croda International to 'underperform' from 'neutral' but left the price target at 3,300p.
Croda is back in vogue, thanks to Brexit and a big pick-up in deal-making in its sectors and investors should 'Buy', The Sunday Times´s Inside the City column said.
Equities in London turned a mildly positive performance ahead of US President Donald Trump's speech before Congress, while US Federal Reserve's interest rate stance was again in focus.
The weak pound helped boost full year pre-tax profits st specialty chemicals firm Croda to £288m from £275m.
Ophir Energy's shares gushed higher after Canaccord Genuity upgraded the stock to 'buy' from 'hold' and lifted the target price to 105p from 80p.